1. Home
  2. FOXX vs VNRX Comparison

FOXX vs VNRX Comparison

Compare FOXX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$4.74

Market Cap

34.0M

Sector

N/A

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.22

Market Cap

35.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXX
VNRX
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
35.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FOXX
VNRX
Price
$4.74
$0.22
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
13.2K
2.3M
Earning Date
02-13-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$62,266,756.00
$1,472,007.00
Revenue This Year
N/A
$55.98
Revenue Next Year
N/A
$420.37
P/E Ratio
N/A
N/A
Revenue Growth
44.85
14.48
52 Week Low
$1.71
$0.21
52 Week High
$8.88
$0.94

Technical Indicators

Market Signals
Indicator
FOXX
VNRX
Relative Strength Index (RSI) 55.66 36.97
Support Level $4.66 $0.21
Resistance Level $5.15 $0.28
Average True Range (ATR) 0.31 0.02
MACD 0.02 -0.00
Stochastic Oscillator 70.34 10.40

Price Performance

Historical Comparison
FOXX
VNRX

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: